New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 9, 2013
10:00 EDTAMTG, PRI, GPN, CYS, QLIK, MVO, HILL, BBT, BCRX, PKI, MAKO, DOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: BB&T (BBT) upgraded to Buy from Neutral at Compass Point... CYS Investments (CYS) upgraded to Buy from Neutral at Compass Point... Dominion (D) upgraded to Overweight from Neutral at Atlantic Equities... Dot Hill Systems (HILL) upgraded to Buy from Hold at Needham... Global Payments (GPN) upgraded to Buy from Neutral at Nomura... MAKO Surgical (MAKO) upgraded to Buy from Neutral at Mizuho... MV Oil Trust (MVO) upgraded to Market Perform from Underperform at Raymond James... Primerica (PRI) upgraded to Outperform from Market Perform at Raymond James... Qlik Technologies (QLIK) upgraded to Overweight from Equal Weight at Evercore... PerkinElmer (PKI) upgraded to Strong Buy from Buy at ISI Group... Apollo Residential Mortgage (AMTG) upgraded to Overweight from Neutral at JPMorgan... BioCryst (BCRX) upgraded to Buy from Hold at MLV Equity.
News For BBT;CYS;D;HILL;GPN;MAKO;MVO;PRI;PKI;QLIK;AMTG;BCRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 3, 2015
16:46 EDTBCRXBioCryst files $150M mixed securities shelf
March 2, 2015
07:28 EDTPRIAssociation of Insurance & Financial Analysts to hold conference
Subscribe for More Information
06:28 EDTBCRXFujifilm CEO says 'ready' for large orders of Avigan drug for Ebola, WSJ reports
Fujifilm’s (FUJIY) Avigan drug, which has shown signs of efficacy against the Ebola virus, has drawn interest from about 20 countries, The Wall Street Journal reports, citing comments made by CEO Shigetaka Komori. The drug was developed by Toyama Chemical, a Fujifilm unit, and Komori said the company is ready for large orders. Other drug companies that are working on experimental Ebola vaccines or treatments include Peregrine (PPHM), Tekmira (TKMR), Sarepta (SRPT), BioCryst (BCRX), Chimerix (CMRX) and NewLink Genetics (NLNK). Reference Link
February 27, 2015
13:24 EDTBCRXLiberia, U.S. begin ZMapp ebola trial
In partnership with the Liberian government, the National Institute of Allergy and Infectious Diseases launched a clinical trial to obtain safety and efficacy data on the investigational drug ZMapp as a treatment for Ebola virus disease. The study may be expanded to test ZMapp against other treatments which may also include the following: Tekmira siRNA from Tekmira Pharmaceuticals (TKMR), Favipiravir from Toyama Chemical, BCX4430 from BioCryst (BCRX), and AVI-7537 from Sarepta (SRPT). The trial is expected to conclude in December 2016.
February 26, 2015
08:31 EDTBBTBB&T received HUD-OIG subpoenas from DOJ in late 2014
Subscribe for More Information
February 20, 2015
10:30 EDTQLIKOptions with decreasing implied volatility
Subscribe for More Information
February 19, 2015
07:08 EDTQLIKQlik Technologies management to meet with Deutsche Bank
Subscribe for More Information
February 18, 2015
16:48 EDTAMTGApollo Residential Mortgage reports Q4 EPS 53c, consensus 51c
The Company’s book value per share of common stock at December 31 was $19.12 as compared to book value per share of common stock of $19.27 at September 30.
06:58 EDTBCRXBioCryst sees FY15 operating expenses $75M-$95M
Subscribe for More Information
06:57 EDTBCRXBioCryst reports Q4 EPS (16c), consensus (21c)
Reports Q4 revenue $5.4M, consensus $3.64M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use